JKJohn Vijay Sagar Kommu

John Vijay Sagar Kommu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John Vijay Sagar Kommu has a total of 179 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Flexible Interview for ICD-11 (FLII-11): Cultural Adaptation and Translation for India

    by T. S. Jaisoorya, Girish N. Rao, Geoffrey M. Reed, Lakshmi Jogi, Karen T. Maré, Ajit B. Dahale, Chethan Raj, Hareesh Angothu, Guru S. Gowda, John Vijay Sagar Kommu, et al.

    The Flexible Interview for ICD-11 (FLII-11) is a new structured diagnostic interview developed by the World Health Organization (WHO) for diagnosing mental disorders based on the ICD-11's clinical descriptions and diagnostic requirements. The instrument is to be used for India’s National Mental Health Survey-2 as the primary assessment instrument for mental health morbidity. This paper outlines the systematic process of culturally adapting the FLII-11 for India. Given India’s immense cultural and linguistic diversity, this was deemed a crucial step to ensure a valid and reliable data collection process. Key steps included: preliminary evaluation by experts for language and cultural congruence; ascertaining the adaptation’s effectiveness in clinical settings; interim analysis, followed by modifications and retesting; and incorporating feedback from both Indian and international collaborators. It also describes the protocol for translating the instrument into 22 recognized Indian languages, ensuring that it can be administered in each state’s language. This project was an international collaboration involving teams from India, South Africa, the UK and the USA. Almost all of the changes made from this study were also incorporated into the current version of the FLII-11, which is being tested in other countries, representing the study’s global contribution of the study.

  • Adverse Childhood Experiences, mental health & social outcomes among institutionalized children – a scoping review

    by Nifi Krishna. T, Mohammed Shamil Hussain, Kavita V. Jangam, John Vijaya Sagar, Senthil Amudan, Mariamma Philip, Rajendra K.M., Priyanka Nambiar

    Around 2.7 million children, aged between 0 and 17 years, are estimated to be residing in institutional care settings worldwide (Petrowski et al., 2017). Poverty, economic hardships, parental chall...

  • Open Access

    Mentalization Profiles of Adolescents with Internalizing Disorders: Domain-specific Differences Compared to Typically Developing Adolescents

    by Arushee Wahi, Bangalore N. Roopesh, John Vijay Sagar Kommu

    Background: Adolescence is a sensitive period for mentalization development and also marks the onset and exacerbation of psychiatric conditions. Mentalization impairments are transdiagnostic, but the literature primarily focuses on younger children and adults in Western cultures, with limited exploration in adolescents. This study aimed to explore the differences between mentalization profiles of adolescents with internalizing disorders (AID) and typically developing adolescents (TDA) in India. Methods: The sample included 166 adolescents (aged 12–17), divided into the AID group ( n = 83) diagnosed with either depression, anxiety, or somatoform/dissociative disorders, and the TDA group ( n = 83) without any psychiatric illness, group-matched on age, gender, and years of formal education. The Mentalization Scale (MentS), the Reflective Functioning Questionnaire for Youth (RFQ-Y), and the Strengths and Difficulties Questionnaire (SDQ) were administered to both groups. In contrast, the Depression Anxiety and Stress Scale for Youth was administered only to the AID group to assess symptom severity. Results: Mann–Whitney U tests revealed the AID group had significantly lower “self-mentalization” (r rb = 0.177) and “Overall mentalization Ability” (r rb = 0.311). No significant differences were found in “other-mentalization” and “motivation to Mentalize.” Spearman’s Rank-Order Correlation revealed that “Overall mentalization ability” was significantly negatively correlated with internalizing and externalizing problems on the SDQ, whereas “motivation to Mentalize” was significantly positively correlated with emotional symptoms on the SDQ. Conclusion: This study highlights differential impairments in mentalization domains between AID and TDA, providing novel insights into mentalization profiles of adolescents through a developmental lens with theoretical and clinical implications in addressing this transdiagnostic vulnerability.


  • Open Access

    Evaluating the efficacy of ayurvedic intervention as add on to conventional treatment and explore the interaction of epigenetics, neuro/gut biomarkers and neuroimaging in pediatric ADHD (attention deficit hyperactivity disorder)

    by Umesh Md (Ay.) Chikkanna, John Vijay Sagar Kommu, Shivakumar V., Bharath Holla, Pallavi Md (Ay.) Mundada, Gokulakrishnan K., Monojith Debnath, Rajendra Md K.M., Roopesh B.N., Srinibash Md (Ay.) Sahoo, et al.

    Introduction: Attention deficit hyperactivity disorder (ADHD) is one of the common neuro-developmental challenges faced by children. Complementary and alternative medicine (CAM) treatments are frequently used as adjuvants to conventional therapy for children with ADHD. However, there are very few randomized controlled trials testing the efficacy of Ayurveda therapies on symptoms of ADHD. Methods: This randomized-controlled study includes patients from an urban tertiary-care hospital, with a between-group, repeated measures, longitudinal design. This study will recruit 80 patients with Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition diagnosis of ADHD. They will be randomly assigned into 2 arms, viz., “Add-on Ayurveda (intervention)” or the “Treatment as usual (TAU)” group with 80 patients in each arm. All the participants will undergo clinical and psychological assessments at baseline and at intervals of 90th day and 180th day. A subset of 32 patients will undergo functional magnetic resonance imaging at the baseline and at 180 days from the baseline. Quantification of serum brain-derived neurotrophic factor, telomere length, beta-endorphins, methylation pattern, and gene expression of various genes will be performed in all 80 subjects at the baseline and after 180 days. Another subset of 40 patients will undergo an assessment of gut-related biomarkers at the baseline and 180 days. Add-on Ayurveda intervention is hypothesized to improve brain function and a child’s behavior as assessed by the above-mentioned parameters in pediatric ADHD. Discussion: Currently, there are no studies in Ayurveda that demonstrate the bio-mechanisms of Ayurveda interventions similar to modern studies. In light of the lack of evidence-based efficacy and safety data and bio-mechanism of these interventions, this study’s findings are expected to have a major impact on establishing the scientific basis for the effects of add-on Ayurveda in neurodevelopmental disorders of childhood, such as ADHD.

  • Open Access

    SMILES: A Child-Centered OCD Recovery Model Derived Through Thematic Analysis

    by Lakshmi Sravanti, Arul Pradeep, John Vijay Sagar Kommu, Rajendra Kiragasur Madegowda, Satish Chandra Girimaji, Shekhar Seshadri

    Background: Obsessive-compulsive disorder (OCD) in children and adolescents presents unique clinical challenges, requiring individualized care. Recovery is a subjective process, and a structured recovery model is needed to guide and support children during their journey. This study explores the meaning of recovery for children with OCD and develops a model that addresses their specific needs throughout treatment. Methods: The central research question aimed to explore the meaning of recovery for children living with OCD. A purposive sampling approach was employed to recruit five participants each from the 7–12 years (children) and 13–17 years (adolescents) age groups, with theme saturation achieved after ten transcripts. Participants were required to have had OCD for at least six months and be in remission. Data were analyzed using thematic analysis, with the final themes synthesized into a conceptual model, SMILES. Ethical approval from the institute and informed consent were obtained from the participants and their parents. Results: Participants identified six key areas of recovery. These areas, derived through inductive thematic analysis, form the components of the recovery model represented by the acronym SMILES, which stands for S ense of self, M ental Health and Well-being, I nstitution of school, L ifestyle, E xtracurricular, and S ocial. The SMILES model can be used in two formats—Rainbow Recovery and Blooming Recovery—based on the child’s preference. Conclusions: The SMILES model can enhance clinical practice by aiding clinicians in establishing a connection with children, thereby facilitating the delivery of holistic care.

  • Open Access

    An Open-label Study to Evaluate Tolerability of Add-on Transcranial Direct Current Stimulation (tDCS) in Adolescents with Schizophrenia or Other Psychotic Disorders

    by Vinayak Koparde, Shivakumar Venkataram, Anushree Bose, John Vijay Sagar Kommu, Ganesan Venkatasubramanian, Satish Chandra Girimaji

    Introduction: Treatment of childhood-onset schizophrenia (COS) and related psychotic disorders is challenging due to limited options for effective interventions. Transcranial direct current stimulation (tDCS) is a noninvasive neuro-modulatory technique found to be safe and effective in adults for treating symptoms of schizophrenia. There is a paucity of studies of tDCS in adolescents regarding its safety and tolerability. We studied the tolerability of add-on tDCS in adolescents with schizophrenia and other psychotic disorders. Material and Methods: Fifteen adolescents with a diagnosis of schizophrenia and other psychotic disorders (ICD 10) with a mean age of 15.25 years, refractory to an adequate trial of antipsychotic and CGI-severity score of 4 (moderately ill) or more were recruited. All patients received 10 sessions of tDCS (2 mA current) with sponge electrodes of 25 sq cm. Adverse effects were measured during each session using a tDCS adverse effect questionnaire, local, general physical, and mental state examination. Results: The most common adverse effects reported were itching and burning sensations (33.3% each) followed by tingling sensation in 20% of subjects at the site of electrode application. Among study subjects, 86.6% had at least one adverse effect, and in 80%, the reported adverse effects were mild. 60% of the reported adverse effects were probably due to tDCS. Conclusion: Adverse effects reported with tDCS are transient. tDCS was tolerable, safe, easily acceptable, and feasible to administer in adolescents with schizophrenia or other psychotic disorders admitted to the hospital.

  • Targeted metabolomics in children with autism spectrum disorder with and without developmental regression

    by Chakkera Priyanka, Rita Christopher, Madhu Nagappa, John Vijay Sagar Kommu, Meghana Byalalu Krishnadevaraje, Durai Murukan Gunasekaran, Binu V. S. Nair, Raghavendra Kenchaiah, Nandakumar Dalavalaikodihalli Nanjaiah, Mariamma Philip, et al.

    Early diagnosis and intervention in children with autism spectrum disorder (ASD) is crucial. At present, diagnosis of ASD is primarily based on subjective tools. Identifying metabolic biomarkers will aid in early diagnosis of ASD complementing the assessment tools. The study aimed to conduct targeted metabolomic analysis and determine the plasma metabolites that can discriminate children with ASD from typically developing children (TD), and to determine the utility of machine learning in classifying ASD children based on the metabotypes. This was a multi-centric, analytical, case-control study conducted between April 2021–April 2023. Fasting plasma samples were obtained from seventy ASD and fifty-eight TD children, aged 2 to 12 years. Samples were quantitively analysed for 52 targeted metabolites (13 amino acids, 37 acylcarnitines, adenosine and 2-deoxyadenosine levels) using tandem mass spectrometry. An in-depth statistical analysis was performed. A total of 26 metabolites (11 amino acids, 14 acyl carnitines and adenosine) were found to be significantly (p < 0.005) different between ASD and TD children. Adenosine and amino acid levels were significantly decreased in ASD children. Among acyl carnitines, short- and long-chain acyl carnitine levels were significantly decreased, while medium-chain acyl carnitine levels were significantly increased in ASD children. Octenoylcarnitine-C8:1 (Cut-off value- 0.025 mmol/L, AUC- 0.683) and adenosine (Cut-off value- 0.025 mmol/L, AUC- 0.673) were found to predict children with ASD at a sensitivity of 55.7% and 57.1%, specificity of 79.3% and 72.4% respectively. Based on the metabolites, machine learning models like Support Vector Machine (SVM) and Random Forest (RF) were able to discriminate ASD from TD children with the classification accuracy score being highest in RF (79.487%, AUC- 0.800). Significant abnormalities in plasma metabolites were observed leading to disturbances in the Krebs cycle, urea cycle and fatty acid oxidation, suggesting mitochondrial dysfunction that may possibly contribute in the pathobiology of ASD. Octenoylcarnitine-C8:1 and Adenosine may serve as potential metabolic biomarkers for ASD.


  • Open Access

    Psychiatric Emergencies in Children and Adolescents: A Comprehensive Profile and Short-term Outcome Evaluation in a Prospective Follow-up Study

    by Prasanna Kumar N, Lakshmi Sravanti, John Vijay Sagar Kommu, Rajendra Kiragasur Madegowda, Shekhar Seshadri, Satish Chandra Girimaji

    Background: Emergency psychiatry services play a critical role in providing essential care for children and adolescents with mental health concerns, yet research in this field, especially in India, is limited. Our study aims to address this gap by investigating the demographic and clinical characteristics and short-term outcomes of children and adolescents accessing emergency psychiatric care at our tertiary care center. Methods: This prospective study included children and adolescents aged 3–18 who presented with psychiatric disorders to emergency services. All cases were assessed using the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria, the Clinical Global Impression (CGI) scale, and the Children’s Global Assessment Scale (CGAS). Follow-ups were done at three weeks and three months. The Shapiro–Wilk test assessed normality, followed by parametric or nonparametric tests as appropriate. Results: The mean age of the sample was 14.8 (standard deviation [SD]: 2.5) years, with boys comprising 57.1% and girls 42.9%. Most visits to emergency services occurred between 1 PM and 6 PM. The most common diagnoses were bipolar affective disorder (23.2%) and conversion/functional neurological symptom disorder (23.2%). Lorazepam and clonazepam were the most commonly prescribed medications at first visit (baseline). At first follow-up (3 weeks), a significant proportion (41.1%) was admitted as inpatients. Olanzapine was the most common drug prescribed during follow-up visits. The CGI scores decreased, while CGAS scores increased, reflecting improved functioning. Conclusions: The significant improvement in CGI and CGAS scores over follow-ups demonstrates the effectiveness of crisis intervention and pharmacotherapy in stabilizing clinical severity and enhancing functioning in the short term.